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ABSTRACT
We propose a new and effective statistical framework
for identifying genome-wide differential changes in
epigenetic marks with ChIP-seq data or gene ex-
pression with mRNA-seq data, and we develop a
new software tool EpiCenter that can efficiently per-
form data analysis. The key features of our frame-
work are: (i) providing multiple normalization
methods to achieve appropriate normalization under
different scenarios, (ii) using a sequence of three
statistical tests to eliminate background regions
and to account for different sources of variation and
(iii) allowing adjustment for multiple testing to control
false discovery rate (FDR) or family-wise type I error.
Our software EpiCenter can perform multiple ana-
lytic tasks including: (i) identifying genome-wide
epigenetic changes or differentially expressed
genes, (ii) finding transcription factor binding sites
and (iii) converting multiple-sample sequencing data
into a single read-count data matrix. By simulation,
we show that our framework achieves a low FDR
consistently over a broad range of read coverage
and biological variation. Through two real examples,
we demonstrate the effectiveness of our framework
and the usages of our tool. In particular, we show
that our novel and robust ‘parsimony’ normalization
method is superior to the widely-used ‘tagRatio’
method. Our software EpiCenter is freely available
to the public.
INTRODUCTION
High-throughput next-gen sequencing (NGS) technologies,
while emerging only 5 years ago, have already been widely
used for biomedical research and discovery. Cost-effective
NGS has almost completely replaced the traditional Sanger
sequencer in genome sequencing and re-sequencing for
discovery of genetic variation. NGS has also extended se-
quencing applications to far broader ﬁelds: studying
DNA–protein interactions and gene regulation, identify-
ing novel transcripts or splice isoforms and detecting dif-
ferentially expressed genes. Indeed, the most powerful
and popular sequencing-based methods, ChIP-seq and
mRNA-seq, are increasingly replacing microarray as the
standard method in these applications. In comparison with
microarray-based methods, these NGS-based methods
offer not only digital readings, larger dynamic signal range
and higher reproducibility but also capabilities such as dis-
covering novel transcripts and studying mRNA polymerase
II pausing (1).
The promising biomedical applications of NGS have
spurred the development of computational tools for ana-
lyzing NGS data. Tools already available for analyzing
ChIP-seq data from genome-wide studies of transcription
factor binding sites (TFBS), a popular early application of
NGS, include: QuEST (2), MACS (3), FindPeaks (4),
CisGenome (5), SISSRs (6), PeakSeq (7) and PICS (8).
These tools identify small genomic regions (e.g. 50–300bp)
with signiﬁcant enrichment of sequencing read tags and
predict the location of binding sites as the peak of read
tags. A recent review by Mortazavi et al. (9) and a com-
parison study by Laajala et al. (10) provide a more com-
plete list of tools and summarize their capabilities and
performance. Other main applications of ChIP-seq
include genome-wide surveys of histone acetylation or
methylation patterns, and identiﬁcation of differential
epigenetic modiﬁcations of histones between different
cell types. Unlike transcription factors, histone proteins
are core components of DNA chromatin. Epigenetic
modiﬁcations of histones typically happen over much
larger genomic regions and often lack the characteristic
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coming an important and popular method for epigenetic
studies, only a few tools [e.g. ChIPDiff (11) and
ChromaSig (12)] are currently available for analyzing
such data.
Another widely used NGS application, mRNA-seq, can
detect novel transcripts, identify differentially expressed
genes, locate full length of transcripts and even map out
the whole transcriptome (13,14). In addition, mRNA-seq
is being used to interrogate post-transcriptional gene regu-
lation including the control of alternative splicing (15)
and polyadenylation (16), RNA editing (17) and degrad-
ation and translation of mRNA. Recent reviews (1,9)
highlight the importance and advantages of mRNA-seq
for these applications. Several tools have been deve-
loped for mRNA-seq data analysis: TopHAT (18),
RNA-Mate (19) and QPALMA (20) are specialized for
aligning reads of mRNA sequences to their genome refer-
ence; ABySS (21) and Velvet (22) are for de novo assembly
of mRNA sequences when a genome reference is either
not available or of low quality; ERANGE (23), RSAT
(24), BASIS (25) and Cufﬂinks (26) assess abundance
of mRNA transcripts; edgeR (27), DESeq (28) and
DEGseq (29) detect differentially expressed genes.
Despite this progress, the development of data analytic
methods lags behind the recent increase in mRNA-seq
applications (30).
We propose a new statistical framework of hypothesis
testing for the comparative analysis of both ChIP-seq and
mRNA-seq data. Our framework is designed to detect gen-
omic regions that differ between cell types or experimental
conditions (denoted as samples) in the density of epigen-
etic markers (ChIP-seq applications) or in the abundance
level of gene transcripts (mRNA-seq applications). In
addition, we introduce several normalization methods,
including our novel ‘parsimony’ method, for adjusting dif-
ferences in read coverage depth between samples. Our
‘parsimony’ method, unlike any traditional method, can
automate data normalization and shows performance
superior to other methods in our examples. To achieve a
low false discovery rate (FDR), our framework employs a
sequence of three tests: the ﬁrst ﬁlters outs background
regions, and the second and third tests act together
complementarily in identifying signiﬁcant changes. The
second test, the exact rate ratio test, uses ‘un-normalized’
read counts to determine whether differences between
samples exceed the expected Poisson variation, assumed
to arise mainly from random experimental processes. The
third test, the z-test, uses log2 ratio data of normalized
read counts to decide whether such differences exceed
the combination of Poisson and other extra variation,
assuming the extra variation is mainly derived from ran-
dom biological processes (see Supplementary Figure S1
for illustration). In addition, we introduce a new software
tool EpiCenter that implements our statistical frame-
work and is freely available to public at http://www
.niehs.nih.gov/research/resources/software/epicenter. This
tool has also been successfully used to analyze several
histone ChIP-seq and mRNA-seq data from multiple
studies (31).
METHODS
Read ﬁltering and noise reduction
To ﬁlter poorly aligned reads and those mapped to mul-
tiple positions, EpiCenter takes advantage of the read
alignment quality scores reported by mapping tools such
as MAQ, or ELAND. These alignment tools assign low
scores to reads that have multiple mismatches (poorly
aligned reads) or that can be aligned to multiple positions
in a genome. By default, EpiCenter ﬁlters out any reads
with alignment quality scores lower than 10, to exclude
reads mapped to repetitive regions and reads aligned
poorly. Users can set the quality-score cutoff to tailor
the read alignment ﬁlter for their speciﬁc applications.
Another main source of noise in sequence reads arises
from non-speciﬁc binding sequences from ChIP experi-
ments or other random sequences from DNA sample
preparation. These noise reads are likely to be randomly
distributed across the genome in the sense that their loca-
tions follow a Poisson process. Let. Lk be the expected rate
of random hits of read tags across the entire genome in
sample k, where k 2 1,2,...,K fg . Under the assumption
that all reads are random noise, Lk can be estimated as
^ Lk ¼
Ck
L
where L is the length of genome reference sequence, and
Ck is the total number of mapped reads in the k-th sample.
EpiCenter uses this estimate by default but allows the
user the option of specifying ^ Lk directly. For a two-sample
comparison, if users specify only ^ L1, EpiCenter will auto-
matically estimate ^ L2 as
^ L1C2
C1 , and vice versa.
Besides this noise-rate-based ﬁltering method,
EpiCenter also offers a way to ﬁlter out background
regions by a user-deﬁned cutoff of an absolute number
of read tags. For example, users can ﬁlter out all regions
with fewer than 10 tags.
Procedures for estimating the read rate ratio and for data
normalization
Background. Variability is introduced in all steps of a se-
quencing experiment and leads to variation in read counts
or coverage depth between different samples, variation
that is unrelated to the biological questions under investi-
gation. The sources of experimental variation include the
amount of input DNA in sample preparation and data
quality from different sequencing lanes and machines. In
addition, one experimental condition can have higher
overall read counts than another simply because it was
sequenced more. To make comparisons fair, a test statistic
must account for such experimental variation that can
change expected read counts. Our exact rate ratio test
does so by adjusting the expected read rate ratio under
the null hypothesis instead of by normalizing the raw
read count data themselves. Our z-test, however, uses
normalized read counts to account for such experimental
variation and biological variation. We developed several
methods, appropriate in different scenarios, for estimating
the expected read rate ratio or for normalizing data.
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procedures.
For all procedures, we divide a genome of length L into
non-overlapping windows (e.g. 1kb windows). Assume
that we have n non-overlapping windows, and let
X1i and X2i be the random variables associated with the
raw counts of read tags in window i from Samples 1 and 2,
respectively. Also, let X
0
1i and X
0
2i be the correspond-
ing normalized counts. Let E be the expectation
function, and R2=1 be the ratio of expected rates for
read counts in Sample 2 over that in Sample 1. We
assume that R2=1 is constant across different windows
indexed by i and that read-tag counts in the window i
follow a Poisson distribution with parameters  ki in
sample k. Since we assume that Xki and Xkj are all inde-
pendent for i 6¼ j, and k 2 1,2 fg ,
P
i Xki also follows a
Poisson distribution with parameters  k ¼
P
i  ki. The
null hypothesis is that the Poisson rates are the same for
both samples after appropriate normalization, that is,
EX
0
2i
  
=EX
0
1i
  
¼ 1. Consequently, using these facts we
can write:
EðX
0
2iÞ
EX
0
1i
   ¼ R2=1  
EX 1i ðÞ
EX 2i ðÞ
¼ R2=1  
P
EX 1i ðÞ
P
EX 2i ðÞ
¼ R2=1  
E
P
X1i
  
E
P
X2i
   ¼ R2=1  
L 1
L 2
¼ 1
From the rightmost equality, we have that
R2=1 ¼
 2
 1
The above equation can be extended to scenarios with
more than two samples, say k 2 1,2, ...,K fg . In such
cases, we use Rk/1 to represent the ratio of expected rates
of reads in sample k over Sample 1. Therefore, under these
assumptions, the only unknown for read count normaliza-
tion is Rk/1. We have developed several approaches to
estimate it.
TagRatio method. The ﬁrst approach, called the tagRatio
method, is the most commonly used in published work
and is appropriate when the sequencing noise level is
similar across samples. The estimate of Rk/1 is simply the
ratio of total number of mapped read tags from the two
samples, namely:
^ Rk=1 ¼
Ck
C1
¼
P
i Xki P
i X1i
, k 2 1,...,K fg
This estimator works best when any biological differ-
ence between the samples has negligible effect on the
overall number read tags as, for example, when an
increase in read tags in some regions is approximately
balanced by a decrease in others.
Parsimony method. We also developed a novel and uncon-
ventional data normalization method that we call the ‘par-
simony’ approach; the term was borrowed from the
parsimony method for phylogenetic tree reconstruction
in evolutionary biology. The parsimony method of tree
building reconstructs a phylogenetic tree by minimizing
the number of DNA base changes of related species.
Following that idea, our ‘parsimony’ normalization
method ﬁnds the best estimate of Rk/1 as the one that
minimizes the number regions/genes that the exact rate
ratio test declares statistically signiﬁcant between two
samples. The key assumption is that biological organisms
always minimize changes of genome or overall gene ex-
pression pattern when adjusting to new genetic/environ-
mental changes. This assumption implies that majority of
regions/genes should not change between samples.
Different from the other methods mentioned above, the
‘parsimony’ method does not estimate the expected ratio
of Poisson rates before statistical testing; instead, it uses
the exact rate ratio test recursively to ﬁnd the optimum
ratio.
Methods based on selection of unchanged regions. A third
general approach is, instead of using all mapped read tags,
to select genomic regions that are believed to have no
biological differences and to use only read counts from
these putative ‘unchanged’ regions for normalization.
Ideally, one uses regions that are known from previous
work to be the same between samples. Without such
a priori knowledge, one could select genomic regions
where both samples have substantial read counts. The
idea is to avoid any region with low counts where a
small change in count for either sample can dramatically
alter sample-speciﬁc ranks and their ratio of read counts
between the two samples. Alternatively, EpiCenter
employs a rank-based approach to select putatively un-
changed regions. After ranking genomic regions separ-
ately by their observed counts for each sample,
EpiCenter selects, as ‘unchanged’, any regions that fall
into a particular range of ranks. The choice of an appro-
priate range of ranks can still be tricky though: if the range
is too small, there may be too few regions included to get a
good estimate; if the range is too large, regions declared
‘unchanged’ may be contaminated with some harboring
real changes. We suggest leaving out the top-ranked 5%
of regions as they are more likely to be repetitive regions
with extremely high depth of read coverage. For example,
one might select regions that, when ranked separately in
each sample, fall between the 90 and 95 percentiles of read
counts in both samples. By selecting top-ranked
non-repetitive regions, we reduce the impact of both the
Poisson variability in read counts, and the uncertainty in
mapping read tags to repetitive regions on the estimation
of Rk/1.
Using these ‘unchanged’, therefore presumed null,
genomic regions, we estimate the expected rate ratio as
the slope of a linear least-squares regression line through
the origin (i.e. intercept set to 0) ﬁtted to pairs of read
counts ðX1i,XkiÞ. In addition, EpiCenter reports both the
mean and median of Xki=X1i as alternative estimates. The
median estimate is more robust to extreme ratios in a few
genomic regions than either the mean or linear
least-squares estimate of Rk=1.
Choice among methods deciding which procedure
might be the best for estimation of Rk/1 or for data nor-
malization may be difﬁcult. Methods based on selection of
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such regions (rarely available in practice) or a trial-and-
error approach where performance could suffer.
Consequently, we focus on the ‘tagRatio’ and ‘parsimony’
methods here. Based on our observations from real and
simulated data, if we ﬁlter out low read count regions, the
log2 ratios of normalized read counts from those regions
declared to be non-signiﬁcant by the exact rate ratio
test has approximately a Gaussian distribution. We use
this observation to motivate our proposed z-test. So, one
way to compare data normalization procedures is just
to assess how well the distribution of log2 ratios from
non-signiﬁcant regions approximates a Gaussian
distribution.
Signiﬁcance tests
Background ﬁltering test. EpiCenter carries out a
sequence of three signiﬁcance tests. The ﬁrst test is
applied to all genomic regions to ﬁlter out any regions
where read tags do not have signiﬁcantly more counts
than expected from random Poisson background noise
in all experimental conditions. This test is done region
by region separately for each condition, and the data are
the total raw read counts in each region. Under the as-
sumption that read counts across the whole genome follow
a Poisson distribution, the P-value for region i in sample
k, Pki, is given by:
Pki ¼ 1   Q Xki+1,liLk ðÞ
where Q is the cumulative distribution of function of the
Poisson distribution, alternatively known as a regularized
gamma function, Xki is the raw read count in a genomic
region i of length li in sample k. The P-value is the prob-
ability of observing Xki or more reads in a genomic region
given the sample-speciﬁc noise rate Lk. A genomic region
is retained for further consideration if this ﬁlter indicates
that the observed counts in the region are enriched
above the background noise for at least one sample, that
is, Pki < 0.05 for at least one sample. Note that the test
will not apply if users choose the noise ﬁlter that is based
on a user-deﬁned cutoff of an absolute number of read
tags.
The exact rate ratio test. The second statistical test in our
sequence is applied only to those genomic regions that
pass the initial background ﬁlter. EpiCenter uses the
exact rate ratio test to determine whether observed differ-
ence in read counts between samples can be explained by
experimental variation. This test statistic assumes that
read counts in a genomic region follow the Poisson distri-
bution, and Poisson rates of different regions within a
sample can be different. Additionally, it assumes that
read counts from different samples are independent. Let
G be a genomic region or gene that consists of m (biologic-
ally) uniform regions. A uniform region is deﬁned as a
contiguous region that is expected to be uniform in read
coverage. So Poisson rates of read tags are the same at all
positions within each uniform region but can be different
between regions.
Now let Xki represent a uniform genomic region
covering li bases. According to the two assumptions
above, Xki   Poissonð kiÞ, which means that Xki is
distributed as a Poisson random variable with per base
rate  ki. We also have
XkG ¼
X m
i¼1
Xki   Poisson
X m
i¼1
li ki=
X m
i¼1
li
 !
¼ Poisson  kG ðÞ
where  kG ¼
Pm
i¼1 li ki=
Pm
i¼1 li. For example, in the
two-sample case, we have X1G   Poisson  1G ðÞ ,
X2G   Poisson  2G ðÞ , and X1G and X2G are independent.
To see whether the genomic region G is differentially
changed between the two samples, we would usually test
the null hypothesis that  1G ¼  2G or, equivalently
 2G= 1G ¼ 1 (given  1G 6¼ 0). However, different samples
may vary in read coverage simply because they differ in
number of sequencing lanes, quality of sequences or se-
quencing machines. Consequently, instead of normalizing
read counts, we test the null hypothesis  2G= 1G ¼ R2=1,
where R2/1 is estimated as described above. Because X1G
and X2G are two independent Poisson random variables,
the distribution of X1G given X1G+X2G ¼ n is a binomial
distribution, i.e., X1j
 
X1+X2 ¼ n
 
  Binomial
 
n,
 1G
 1G+ 2G
 
,
or, under our null hypothesis, Binomial
 
n, 1
1+R2=1
 
. Based
on this theory, we construct the exact binomial test stat-
istic for testing the null hypothesis that  2G= 1G ¼ R2=1.
We call this test the exact rate ratio test. This approach
can be extended to cases with more than two samples by
making pairwise comparisons.
z-test of log2 ratios. The third statistical test in our
sequence is designed to ﬁnd those genomic regions or
genes whose rate ratio (or fold change) between samples
is extreme in comparison to the expected distribution of
rate ratios across the genome. The second test determined
which regions have different Poisson rates between two
samples, but its adjustment for different overall rates be-
tween samples via R2=1 does not fully allow for biological
variation or other extra variation. Simply comparing
P-values from that test across genomic regions has draw-
backs because genomic regions with high depth of cover-
age will have smaller P-values than regions of low depth of
coverage even if ratio of Poisson rates is the same for both
regions. To take fuller account of extra variability in
estimated rate ratios, we take as data the log2 ratios of
read counts in the two samples and construct a z-test by
assuming a Gaussian distribution for the log2 ratio. We
present the z-test here for two samples, but it can be
applied to any pairwise comparison if there are more
than two samples. The log2ratio of read tags between
two samples j and k in genome region i, denoted Ziðj,kÞ,
is deﬁned as:
Zi j,k ðÞ ¼ log2
X
0
ji+1
X
0
ki+1
 !
where X
0
ji and X
0
ki denotes the normalized read counts in
the same region i from sample j and sample k, respectively.
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ChIP-seq and mRNA-seq data that the distribution of
the log2 ratios between two samples closely approximates
a Gaussian distribution, after ﬁltering out genomic regions
of low read count (<10) and regions changed signiﬁcantly
(as declared by the exact rate ratio test), which is
illustrated in two real-data examples. We also supported
this observation using simulations generated under a
broad range of Poisson rates of read tags and the degree
of extra biological variation (see ‘Materials and Methods’
for simulation procedures). The simulation showed that in
both scenarios with or without biological variation, the
log2ratio distributions of read counts between two
samples, after ﬁltering our low read count regions,
closely approximate a Gaussian distribution (see Figure 1
for examples). Since the expected value of
X
0
ji+1
X
0
ki+1 of un-
changed regions is 1, the distribution of Zi j,k ðÞ under our
null hypothesis has mean zero. Our z-test takes, as its null
distribution, a Gaussian distribution with mean zero and
an estimated standard deviation. Depending on available
data, we suggest different methods for estimating the
standard deviation (see Supplementary Figure S2). When
biological replicates are not available, EpiCenter estimates
by default the standard deviation of this null distribution,
after ﬁltering out regions with <10 read tags, from regions
declared to be non-signiﬁcant by the exact rate ratio test.
The null standard deviation can also be speciﬁed by users
as an option.
Determining signiﬁcance of change. The exact rate ratio
test and the z-test are different, and thus one test can
indicate that a region is signiﬁcantly changed between
samples whereas the other may not. The exact rate ratio
test tends to have a high false positive rate when biological
or other variation contributes substantially to read count
difference between samples. The exact rate ratio test is
especially sensitive when read counts are large. The
z-test is more robust against extra variation, but does
not work well when read counts are low. In this sense,
the two tests are complementary. Consequently, we
combine results from both tests by taking the maximum
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Figure 1. The null distribution of log2ratio of simulation data. The plot shows histograms of log2 ratio of read counts between two independent
samples. The red dotted line in each histogram is the Gaussian approximation to the histogram. The simulation data were generated under different
Poisson rates with/without imposing biological variation: (A) read simulated under one Poisson rate (0.01) and no biological variation; (B) read
simulated under the Poisson rate 0.1 and no biological variation; (C) read simulated under the Poisson rate 1 and no biological variation; (D) read
simulated under different Poisson rates (rates ranging from 0.01 to 10) and different levels of biological variation (SD ranging from 0 to 0.3).
The simulation results show that the log2ratio of read counts can be well approximated by the Gaussian distribution when the average number of
read tag per regions is >10.
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region, and use its value to determine whether the region is
signiﬁcant.
Simulation analysis of log2ratio null distribution
We used simulation to investigate whether the null distri-
bution of the log2ratio approximates a Gaussian distribu-
tion. We simulated read counts of mRNA-seq data for
two independent samples. Each simulated data set incl-
uded 10000 independent genes, each of length 1000bp,
and read counts were simulated for two independent
samples under two scenarios: (i) read count data having
only Poisson variation by mimicking only experimental
variation, and (ii) read count data containing both
Poisson variation and additional variation by mimicking
both experimental variation and biological variation. For
the ﬁrst scenario, read counts of two samples were
generated from an identical Poisson distribution, and we
simulated 20 data sets, each with different Poisson rates:
0.01, 0.03, 0.05, 0.07, 0.09, 0.1, 0.3, 0.5, 0.7, 0.9, 1, 2, 3, 4,
5, 6, 7, 8, 9 and 10. For the second scenario, we simulated
a total of 200 data sets, each under a combination of the
same 20 Poisson rates and 10 levels of extra variation
(mimicking biological variation) in log2ratio as governed
by Gaussian distributions with mean 0 and 10 levels of
standard deviation: 0.01, 0.03, 0.05, 0.07, 0.09, 0.1, 0.2,
0.3, 0.4, 0.5. For each data set in the second scenario, we
simulated read counts through the following three main
steps: ﬁrst, we generated gene-speciﬁc 10000 log2ratios at
random from a Gaussian distribution of mean 0 and a
given standard deviation; second, for each gene for the
ﬁrst sample, we generated a random Poisson read count
using a given Poisson rate and third, for each gene in the
second sample, we used its gene-speciﬁc log2ratio and the
given Poisson rate to calculate the adjusted Poisson rate
applicable to the gene. We then used the adjusted Poisson
rate to generate an independent Poisson read count for the
gene. In both simulation scenarios, all genes whose
maximum read count in both samples was less than 10
were removed from each simulated data set before
estimating the null distribution of log2ratio.
Data simulation for performance assessment
We assessed the performance of our method in a simu-
lation study involving 9500 unchanged and 500 differen-
tially expressed genes, each of length 1000bp. The fold
changes of the 500 differentially expressed genes were uni-
formly distributed between 1.5 and 10. We modeled dif-
ferent depths of read coverage with 15 different Poisson
rates: 0.1, 0.3, 0.5, 0.7, 0.9, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10
tags per genomic position. We modeled nine levels of extra
variation as biological variation in log2ratio with nine
zero-mean Gaussian distributions of different standard
deviations: 0 (no extra variation), 0.01, 0.03, 0.04, 0.05,
0.07, 0.09, 0.1 and 0.2. We simulated read counts inde-
pendently for two samples, each with two independent
‘biological’ replicates. In total, we generated 135 data
sets, each under one of the possible combinations of 15
levels of read coverage and 9 levels of extra variation. We
analyzed each data set independently. Using the Bonferroni
correction for multiple testing, we set the cutoff P-value for
statistical signiﬁcance for our Max-P statistic to 5 10
 6.
For each combination of read coverage and extra vari-
ation, we calculated the false positive rate (FPR) as the
proportion of the 9500 unchanged genes rejected by
the test, the false negative rate (FNR) as the proportion
of the 500 differentially expressed genes not rejected by the
test, and the FDR as the ratio of the number of genes
rejected among the 9500 unchanged genes to the total
number of genes rejected. We repeated each simulation
eight times, and reported the average of each measure.
RESULTS
We developed a new statistical framework as detailed in
the ‘Methods’ section for the analysis of NGS data ana-
lysis. We also built a versatile new software tool,
EpiCenter, to allow researchers to customize their analyses
of both ChIP-seq and mRNA-seq data (Figure 2).
EpiCenter can identify epigenetic changes in the whole
genome or in selected genomic regions (e.g. promoters),
detect differentially expressed genes using either genomic
sequences or cDNA sequences and locate TFBS.
EpiCenter can also convert ChIP-seq or mRNA-seq data
into a simple data matrix of read counts, allowing direct
use of some existing tools for data analysis. For example,
users can convert multiple-sample mRNA-seq data into a
single matrix of read counts and use Cluster (32) and
TreeView (33) for clustering analysis and visualization.
In addition, EpiCenter can generate compressed or
uncompressed WIG data ﬁles for visualization in the
UCSC genome browser and supports multiple major
read alignment formats such as MAQ (34), ELAND,
SAM and BAM. EpiCenter is computationally efﬁcient,
with typical running time <10min and peak memory
usage <4GB. The running times for both examples of
real-data applications below were <5min on 64-bit
Linux with 2.93GHz Intel Xeon CPU. The test data and
codes are available at http://bioinformatics.joyhz.com/
epicenter.
Performance on simulated data
We used simulations to assess EpiCenter’s performance
based on the Max-P statistic (see ‘Materials and
Methods’ for details of simulation). The simulation
generated 135 independent data sets of 10000 independent
genes, among which 500 were differentially expressed
between the two treatment samples. Each data set,
having two replicates for each of two samples, involved
different depths of read coverage (overall Poisson rates)
or degrees of extra variation in log2ratio between condi-
tions. For each data set, we performed two separate
analyses: one using only a single replicate (i.e. without rep-
licates), and the other using both replicates (i.e. with repli-
cates). Without replicates, EpiCenter ﬁrst selected
‘unchanged genes’ by the exact rate ratio test, then
estimated the standard deviation of the log2ratios from
these ‘unchanged genes’. The P-value cutoff for the exact
rate ratio test was 0.01, adjusted by the Bonferroni’s cor-
rection. With replicates, EpiCenter took, as the estimated
e130 Nucleic Acids Research, 2011,Vol.39, No. 19 PAGE 6 OF 14standard deviation of log2ratios, the average of the
standard deviations of two replicates of each sample. We
calculated FPRs, and FNRs and FDRs from each analysis,
and reported the mean of each measure under each simu-
lation combination.
Replicates improved the performance of the Max-P stat-
istics compared to analyses without replicates (Figure 3A
versus B). This improvement arises, in part, because the
estimation of the standard deviation of log2ratios becomes
more precise with replicates present and, in part, because
the second replicate increases overall number of read
counts for each gene.
Using the same simulated data and the same P-value
cutoff for signiﬁcance, we compared the performance of
EpiCenter with the latest versions edgeR (version 2.2.5)
and DEGseq (version 1.0.0). We ran both edgeR and
DEGseq under their default settings in scenarios with
and without replicates. Without replicates, edgeR had
high FPR and FDR when read coverage was high and
extra variation was substantial (see Supplementary
Figure S4); with replicates, edgeR had very high FNR,
possibly resulting from overestimation of the dispersion
parameter of the negative binomial distribution (data not
shown). DEGseq showed similar performance whether
using replicates or not (Supplementary Figure S5).
When read coverage was high and extra variation was sub-
stantial, DEGseq had high FPR and FDR. In comparison,
EpiCenter achieved much lower FPR and FDR in most
scenarios (Figure 3) and its performance improved when
replicates were used.
Examples of real data analysis
Example 1: Analysis of histone ChIP-seq data
Data set. We used a histone ChIP-seq data set from a
study of the epigenetic proﬁling of the X chromosome dur-
ing X inactivation (GEO access number GSE15814) (35).
To identify epigenetic changes associated with X inactiva-
tion, the study generated the epigenetic ChIP-seq proﬁle of
H3K27me3 for mouse male (E14) and female (LF2) em-
bryonic stem (ES) cells, together with their differentiated
derivative 10-day embryoid bodies (10dEB). Our analysis
was to detect changes in H3K27me3 epigenetic marks
between the ES cells and 10dEB cells in males, and separ-
ately, in females, and then to identify epigenetic changes
associated with X inactivation in females by comparing ES
versus 10dEB changes between males and females.
The data set contains a total of 19 lanes of H3K27me3
sequencing data: 4 for male ES cells (E14-undiff), 6 for
male 10dEB cells (E14-10dEB), 4 for female ES cells
(LF2-undiff) and 5 for female 10dEB cells (LF2-10dEB).
Figure 2. Illustration of EpiCenter’s approach for two-sample mRNA-seq or ChIP-seq data analysis.
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(UCSC mm9). The numbers of uniquely mapped reads in
millions for the four cell types are: 5.92 for E14-undiff,
8.62 for E14-10dEB, 6.51 for LF2-undiff and 7.50 for
LF-10dEB.
Choice of genomic regions and read normalization
method. For comparative analysis of the abundance of
H3K27me3 epigenetic marks, we selected a genomic
region for each gene that included the entire gene region
(exons and introns) and a 1000bp upstream promoter
region. H3K27me3 epigenetic marks within this region
presumably have major effects on control of in gene tran-
scription (35). We applied EpiCenter’s type ‘31’ analysis
(see EpiCenter Manual at http://www.niehs.nih.gov/
research/resources/software/epicenter/docs/epicenter-
manual.pdf), which allows users to easily select a gene and
its ﬂanking regions for comparative analysis.
We chose, via an option in EpiCenter, not to normalize
read counts by the length of gene region for two reasons: (i)
mouse genes vary substantially in length, from over
2 million bp (e.g. Dmd, Cntnap2) to just over a few
h u n d r e db p( e . g .Hist1h2ba, Prm3); (ii) the abundance of
H3K27me3 is expected to change across different regions of
a gene. A consequence of a non-uniform distribution of
reads is that an initial ﬁlter based on an estimated global
noise rate tends to be problematic. Instead, we ﬁltered out
geneswiththemaximumreadcounts<60oftwosamplesin
each comparative analysis. After ﬁltering, we had over
10000 genes remaining in both male and female samples.
We compared the ‘tagRatio’ and ‘parsimony’ methods
for estimating the expected rate ratio between E14-undiff
and E14-10dEB (denoted RE14), and between LF2-undiff
and LF2-10dEB (denoted RLF2). The estimates given by
‘tagRatio’ are 0.69 for RE14, and 0.87 for RLF2, while the
ones given by ‘parsimony’ are 0.72 for RE14, and 0.91 for
RLF2. Both Gaussian-ﬁt plots and Lilliefors’s test for nor-
mality indicated that ‘parsimony’ achieved normality
better than did ‘tagRatio’ for the distribution of log2ratios
among genes declared non-signiﬁcant by the exact rate
ratio test (Figure 4). Overall, using the Max-P statistic,
the ‘parsimony’ method resulted in fewer genes being
declared as having signiﬁcantly differential enrichment
of H3K27me3 in the LF2-10dEB versus LF2-undiff com-
parison than did ‘tagRatio’ method; however, ‘parsimony’
declared a larger number of genes to be signiﬁcantly more
abundant H3K27me3 in LF2-10dEB than in LF2-undiff
cells, than ‘tagRatio’ did (Figure 5).
Identiﬁcation of genes associated with X inactivation. In
female cells, we identiﬁed 173 genes in the chromosome
X (chrX) that had signiﬁcantly higher enrichment of
H3K27me3 in LF2-10dEB than in LF2-undiff. In
contrast, we found only 11 genes in chrX that had
higher enrichment in E14-10dEB than E14-undiff in
male cells (Figure 6). Among 173 differentially marked
genes in the LF2 comparison, 165 were female-speciﬁc
(the remaining 8 genes were differentially marked in the
E14 comparison also). The large number of female-speciﬁc
differentially marked genes conﬁrms that that X
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Figure 3. Performance comparison of the Max-P statistic with and without replicates. (A) without replicates, the standard deviation of z-test was
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gene expression ratios.
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analysis also conﬁrms that the Tsix gene had higher abun-
dance of H3K27me3 in 10dEB cells than in stem cells in
both male and female, and that the gene Pgk1, a classical
example of a gene that inactivates during X inactivation,
had signiﬁcantly more abundance of H3K27me3 in female
LF2-10dEB cells than LF2-undiff cells, as reported in the
original article of the data set (35).
Example 2: detecting differentially expressed genes with
mRNA-seq data
Data set. We used an mRNA-seq data set of head tissue
from Drosophila melanogaster, which was generated by the
Encyclopedia of DNA Elements (ENCODE) and model
organism ENCODE (modENCODE) Projects funded by
NHGRI. The goal of our analysis was to identify genes
differentially expressed in head tissue between females and
males. The mRNA data consisted of six lanes of sequenc-
ing reads (three each for male and female head tissue)
generated by Illumina Genome Analyzer II. This data
set is publically available at NCBI genomics data reposi-
tory GEO with access number GSE20348.
Choice of DNA references for read mapping. EpiCenter’s
procedure for mRNA-seq data analysis differs depending
on whether reads are mapped to the whole genome refer-
ence or to gene cDNA sequences directly. If reads are
mapped to the whole genome reference, reads from exon
undiff 10dEB undiff 10dEB
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Figure 4. Comparison of the distributions of log2ratios for non-signiﬁcant regions between LF2-undiff and LF2-10dEB cells based on the ‘tagRatio’
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 4, while the P-value given to the ‘parsimony’ histogram is 0.0124.
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mismatches from aligning part of a read to introns
between exons. For the same reason, fewer reads can be
aligned to short exons, especially those of length less than
the length of the read. This problem is avoided when
mapping reads directly to cDNA sequences of genes.
One caveat, however, involves genes with two or more
isoforms due to alternative splicing: some reads can be
equally well aligned to multiple isoforms even if they
arise mainly from one isoform. How to best align reads
to multiple isoforms remains a nontrivial issue. To
sidestep it, one can align reads to a set of unique cDNA
sequences from which the cDNA sequences of alternative
isoforms are removed; alternatively, one can put cDNA
isoforms into different sets of cDNA sequences, each con-
taining only one isoform, then map reads separately for
each set. For simplicity, we here chose to map reads to a
set of unique cDNA sequences.
We downloaded the full set of cDNA sequences of
D. melanogaster (r5.31) from Flybase at http://ﬂybase
.org, and extracted a set of unique cDNA sequences by
retaining only the ‘RA’ isoforms of each gene. We used
MAQ with its default settings to map reads to this unique
cDNA set. In total, 8.61 and 9.63 million reads were
mapped in male and female samples, respectively.
Since sequencing reads were mapped to cDNA sequences
directly, we applied EpiCenter’s ‘type 32’ analysis to identify
differentially expressed genes between male and female
tissue. Since reads from mRNA-seq can be typically
assumed to uniformly cover the full length of mRNA,
we normalized read counts of each gene by its mRNA
sequence length. An advantage of using such length-
normalized read counts is that we can use them to compare
relative gene expression levels across genes of different
lengths. We used Max-P to determine the statistical sig-
niﬁcance of differences in expression levels because it ac-
commodates substantial biological and/or other extra
variation in gene expression. We ﬁrst used the ‘tagRatio’
read-normalization method, the one widely used for
mRNA-seq studies, to estimate the expected rate ratio
R2/1 between male and female samples. We did the same
analysis with our ‘parsimony’ method and compared
results to assess performance of the two methods. The
estimate of R2/1 is 0.89 by ‘tagRatio’ and is 0.97 by ‘par-
simony’ method, where sample 1 and 2 were from male
and female, respectively. The difference in the two R2/1
estimates led to substantially different results. At the 5%
FDR (Benjamini-Hochberg) cutoff threshold, the
‘tagRatio’ method reported a total of 883 differentially
expressed genes, with 518 more highly expressed in male
tissue and 365 in female tissue; whereas the ‘parsimony’
method reported 892 differentially expressed genes, with
339 more highly expressed in male tissue and 553 in female
tissue. To examine why the two normalization procedures
gave different results, we looked closely at scatter plots of
raw read counts (Figure 7). We found that three yolk
protein genes (Yp1, Yp2 and Yp3) were highly expressed
in female tissue and ninaE was extremely highly expressed
in both male and female tissue. These four genes were
highly inﬂuential on the ‘tagRatio’ estimate of the rate
ratio but not on the ‘parsimony’ estimate. For example,
by removing Yp1 alone, the ‘tagRatio’ method estimated
the rate ratio as 0.91 and reported 473 genes of signiﬁ-
cantly higher expression in male tissue and 401 in female
tissue; by removing all four genes, the ‘tagRatio’ method
estimated the rate ratio as 0.93 and reported 427 genes of
signiﬁcantly higher expression in male tissue and 438 in
female tissue. In contrast, the ‘parsimony’ method gave
the same rate ratio estimate and consistent numbers of
differentially expressed genes in male or female tissue
despite omission of these inﬂuential genes. We further
compared the two normalization methods by assessing
how well the log2ratios for those genes selected by each
method to estimate the null distribution approximated the
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Figure 6. Comparison of number of signiﬁcant Chromosome X genes in male (E14) and female (LF2) cells. (A) genes of E14 Chromosome X,
(B) genes of LF2 Chromosome X. In both plots, genes in red have signiﬁcantly higher enrichment of H3K27me3 in un-differential cells, while genes
in green have more abundance of H3K27me3 in 10EB cells. X inactivation led to a signiﬁcant increase in H3K27me3 epigenetic marks for 173 genes
in LF2-10dEB, while without X inactivation, only 11 genes showed a signiﬁcant increase of H3K27me3 in E14-10dEB.
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Q–Q plots and normality tests, indicated that the
log2ratios of genes selected by the ‘parsimony’ method
were closer to a Gaussian distribution than those of
genes selected by the ‘tagRatio’ (Figure 8). These results
suggest that the ‘parsimony’ method provided better nor-
malization for our testing procedure than did the
‘tagRatio’ method. Among all signiﬁcantly differentially
expressed genes, besides the three yolk protein genes that
were highly over-expressed in female tissue compared to
male tissue, the gene Odorant-binding protein 99b
(Obp99b) was highly underexpressed (Figure 9).
DISCUSSION
Despite great progress to date in developing statistical
methods and tools for analyzing NGS data, data
analysis remains a bottleneck to the use of NGS in bio-
medical research. The bottleneck is due in part to three
issues: (i) the challenge of dealing with the huge volume of
NGS data, (ii) the rapid evolution of NGS technologies
and emergence of new ones and (iii) new applications of
NGS. We presented a novel statistical framework and a
new software tool, EpiCenter, for analysis of both
ChIP-seq and mRNA-seq data, and we demonstrated by
simulation and real examples the effectiveness of our
approach. Unlike existing methods that mostly rely on a
single test, our method uses a combination of two main
tests for determining which regions or genes are changed
between samples. Our simulation study showed that our
Max-P statistic was robust in controlling the FDR against
multiple sources of variation. Our method is mainly
designed for analyzing histone ChIP-seq data and
mRNA-seq data for identifying epigenetically changed
genomic regions or differentially expressed genes, but it
can be also used for peak-ﬁnding analysis of transcription
factor ChIP-seq data when sequencing both control and
ChIP samples. In fact, our comparative approach would
be particularly useful at detecting differential binding if
two ChIP-seq studies for the same transcription factor
were run on samples from different tissues or samples
generated under different exposure conditions. For peak-
ﬁnding analysis, users are encouraged to use EpiCenter
together with other tools (e.g. QuEST, MACS) specialized
for this purpose.
Our method has several underlying assumptions. Our
tests for detecting signiﬁcant differences between samples
explicitly allow different regions to have different depths
of coverage. Our exact rate ratio test assumes a Poisson
distribution of read tags but allows the Poisson rates
change across regions. This assumption is more realistic
than the single Poisson rate assumption. When data meet
the Poisson assumption, the exact rate ratio test is powerful
for detecting changes in genomic regions with moderate/
large read counts. On the other hand, the exact test itself
does not account for biological or other extra variation be-
tween samples. Consequently, statistical signiﬁcance based
on the exact rate ratio test alone should be regarded cau-
tiously because differences in read counts declared statis-
tically signiﬁcant may simply reﬂect such additional
sources of variation, especially when read counts are
high. For that reason, our framework includes the z-test
on log2ratios of normalized read count data in an effort to
account for the extra-Poisson variation, and thereby, to
reduce the FDR. One additional assumption underlying
the z-test is that the log2ratio of read counts has approxi-
mately a Gaussian distribution. As suggested by our simu-
lations, this approximation holds when: (i) the number of
read tags in individual genomic regions is over 10—a re-
quirement that is often satisﬁed in real data or that can be
met by using larger regions and (ii) biological or other
extra variation accounts in part for differences in read
counts between samples. Data we have seen appear to
meet, at least approximately, the assumption that the
log2ratio in non-differentially expressed genes follow a
Gaussian distribution. Under all these assumptions, our
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Figure 7. Scatter plots of raw read counts of male and female mRNA-seq data. In all three plots, dots in red are genes of signiﬁcantly higher expres-
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normalization method. A and B show genes that have read counts  3000, while C shows all genes. The blue dotted lines in each plot are the
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coverage variation across different genomic regions and
biological variation between samples.
Another distinct feature of our method is that our exact
rate ratio test statistic operates directly on the original
data, instead of on the normalized data, but takes
account of the need for normalization by adjusting the
null hypothesis. The choice of an appropriate normaliza-
tion method is, nevertheless, critical to successful data ana-
lysis. As seen in our real application involving tissue from
D. melanogaster, our ‘parsimony’ method and the widely-
used ‘tagRatio’ method led to different conclusions about
how many genes were over- versus under-expressed in
male compared to female tissue. We found that the
‘tagRatio’ method was sensitive to outliers compared to
the ‘parsimony’ method. In addition, in both the real
examples presented here, our novel ‘parsimony’ method
selected genes whose log2ratios exhibited a more nearly
Gaussian distribution than those genes selected by the
‘tagRatio’ method. Consequently, the ‘parsimony’ method
seemed the more appropriate normalization approach for
use with our testing procedures. Of course, users should be
aware that no single normalization method will be appro-
priate for all data or with all testing approaches. Because
the conclusions drawn from a ChIP-seq or mRNA-seq
analysis can be sensitive to an analyst’s choice of normal-
ization method, the choice must be made with care.
Additional research is needed to provide guidance to in-
vestigators about how to choose a normalization method
that is best suited to the particular problem at hand.
Data replicates, especially, biological replicates can
increase the power for identifying signiﬁcant genes. This
is true to our statistical method too. For example, with
increase in the number of replicates, and hence the depth
of read coverage across the genome reference, we can
increase statistical power of our exact rate ratio test. As
shown in our simulation experiment, we can get a more
accurate estimate of biological variation (the null standard
deviation of log2ratio) by increasing data replicates.
Especially, we can get a more conﬁdent estimate of bio-
logical variation if we estimate it directly from biological
replicates. We also typically see substantially larger vari-
ation between biological replicates than between technical
replicates for ChIP-seq and mRNA-seq data. In this sense,
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Figure 8. Comparison of log2ratio null-distributions estimated from ‘tagRatio’ and ‘parsimony’ normalization methods. Upper panel are plots of
data selected by the ‘tagRatio’ method for estimating log2ratio null-distribution: (A) the log2ratio histogram and (B) the normality Q–Q plot.
Bottom panel are plots of data selected by the ‘parsimony’ method for estimating log2ratio null distribution: (C) the log2ratio histogram and (D) the
normal Q–Q plot. The red line in either plot (A or C) is a Gaussian distribution ﬁt plot of histogram data. Both histogram and QQ normality plots
show ‘parsimony’ data are ﬁtted better with a Gaussian distribution than ‘tagRatio’ data. This result was conﬁrmed by the Lilliefors’s normality test
results. The test rejected normality of ‘tagRatio’ data with P-value 4.906 10
 5, while accepted normality of ‘parsimony’ with P-value 0.25.
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We often get, however, fewer biological replicates than
technical replicates in available ChIP-seq or mRNA-seq
data from published studies, partly due to still expensive
NGS. Therefore, we would like to emphasize that bio-
logical replicates are important in identifying differential
changes, and cannot be substituted by technical replicates
though technical replicates are helpful when a single run
does not provide sufﬁcient read coverage. Without bio-
logical replicates, no method can eliminate a ﬂuke
pattern attributable to some idiosyncrasy of a particular
biological sample.
In summary, we proposed a new statistical frame-
work and developed an efﬁcient software tool to compara-
tively analyze NGS data for detecting changes in
epigenetic marks or gene expression. We showed
that our method was robust in controlling the FDR by
simulation, and we demonstrated that our software tool
was practically efﬁcient through two real examples of data
analysis. Our software EpiCenter is freely available to the
public at http://www.niehs.nih.gov/research/resources/
software/epicenter.
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Figure 9. Normalized read coverage plots of some top differentially expressed genes between male and female drosophila head tissue. The left side
shows genes from the male sample, and the right side shows genes from the female sample. X-axis is position relative to the gene transcription start
site, and Y-axis is normalized read coverage depth. Red dotted lines are boundaries of neighboring exons. The ﬁgure shows that reads were equally
well mapped to exon boundary regions and non-boundary regions, as expected from mapping reads directly to cDNA sequences.
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